GIANFILIPPI, Gianluca
GIANFILIPPI, Gianluca
DIREZIONE OFFERTA FORMATIVA, SERVIZI E SEGRETERIE STUDENTI
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
2021-01-01 Salvagno, Gian Luca; Henry, Brandon M.; di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gian Luca; Lippi, Giuseppe
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
2021-01-01 Salvagno, Gian Luca; Henry, Brandon; Di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gianluca; Lippi, Giuseppe
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity
2023-01-01 Salvagno, Gian Luca; Pighi, Laura; Henry, Brandon M; Valentini, Myriam; Tonin, Beatrice; Bragantini, Damiano; Gianfilippi, Gianluca; De Nitto, Simone; Plebani, Mario; Lippi, Giuseppe
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay
2023-01-01 Pighi, Laura; Henry, Brandon M; De Nitto, Simone; Gianfilippi, Gianluca; Salvagno, Gian Luca; Plebani, Mario; Lippi, Giuseppe
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test
2021-01-01 Salvagno, Gian Luca; Gianfilippi, Gianluca; Bragantini, Damiano; Henry, Brandon M; Lippi, Giuseppe
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination
2022-01-01 Lippi, Giuseppe; Salvagno, Gian Luca; Henry, Brandon M.; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
2022-01-01 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects
2022-01-01 Salvagno, GIAN LUCA; Henry, Brandon M.; Pighi, Laura; DE NITTO, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Impact of the COVID-19 pandemic on the volume of laboratory testing
2023-01-01 Pighi, Laura; Henry, Brandon M.; DE NITTO, Simone; Gianfilippi, Gianluca; Raschella, Nicola; Salvagno, GIAN LUCA; Lippi, Giuseppe
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers
2022-01-01 Salvagno, Gian Luca; Henry, Brandon Michael; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay
2021-01-01 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals
2022-01-01 Salvagno, Gian Luca; Nocini, Riccardo; Gianfilippi, Gianluca; Fiorio, Giacomo; Pighi, Laura; De Nitto, Simone; Cominziolli, Annalisa; Henry, Brandon M; Lippi, Giuseppe
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit
2021-01-01 Salvagno, Gian Luca; Gianfilippi, Gianluca; Pighi, Laura; De Nitto, Simone; Henry, Brandon M.; Lippi, Giuseppe
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test
2023-01-01 Pighi, Laura; Henry, Brandon M; De Nitto, Simone; Gianfilippi, Gianluca; Salvagno, Gian Luca; Lippi, Giuseppe
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters
2022-01-01 Salvagno, Gl; Henry, Bm; Pighi, L; De Nitto, S; Gianfilippi, G; Lippi, G.
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster
2022-01-01 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
2021-01-01 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination | 1-gen-2021 | Salvagno, Gian Luca; Henry, Brandon M.; di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gian Luca; Lippi, Giuseppe | |
| Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers | 1-gen-2021 | Salvagno, Gian Luca; Henry, Brandon; Di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gianluca; Lippi, Giuseppe | |
| Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity | 1-gen-2023 | Salvagno, Gian Luca; Pighi, Laura; Henry, Brandon M; Valentini, Myriam; Tonin, Beatrice; Bragantini, Damiano; Gianfilippi, Gianluca; De Nitto, Simone; Plebani, Mario; Lippi, Giuseppe | |
| Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay | 1-gen-2023 | Pighi, Laura; Henry, Brandon M; De Nitto, Simone; Gianfilippi, Gianluca; Salvagno, Gian Luca; Plebani, Mario; Lippi, Giuseppe | |
| Clinical assessment of the Roche SARS-CoV-2 rapid antigen test | 1-gen-2021 | Salvagno, Gian Luca; Gianfilippi, Gianluca; Bragantini, Damiano; Henry, Brandon M; Lippi, Giuseppe | |
| Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination | 1-gen-2022 | Lippi, Giuseppe; Salvagno, Gian Luca; Henry, Brandon M.; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca | |
| Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals | 1-gen-2022 | Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe | |
| Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects | 1-gen-2022 | Salvagno, GIAN LUCA; Henry, Brandon M.; Pighi, Laura; DE NITTO, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe | |
| Impact of the COVID-19 pandemic on the volume of laboratory testing | 1-gen-2023 | Pighi, Laura; Henry, Brandon M.; DE NITTO, Simone; Gianfilippi, Gianluca; Raschella, Nicola; Salvagno, GIAN LUCA; Lippi, Giuseppe | |
| Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers | 1-gen-2022 | Salvagno, Gian Luca; Henry, Brandon Michael; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe | |
| Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay | 1-gen-2021 | Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe | |
| Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals | 1-gen-2022 | Salvagno, Gian Luca; Nocini, Riccardo; Gianfilippi, Gianluca; Fiorio, Giacomo; Pighi, Laura; De Nitto, Simone; Cominziolli, Annalisa; Henry, Brandon M; Lippi, Giuseppe | |
| Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit | 1-gen-2021 | Salvagno, Gian Luca; Gianfilippi, Gianluca; Pighi, Laura; De Nitto, Simone; Henry, Brandon M.; Lippi, Giuseppe | |
| Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test | 1-gen-2023 | Pighi, Laura; Henry, Brandon M; De Nitto, Simone; Gianfilippi, Gianluca; Salvagno, Gian Luca; Lippi, Giuseppe | |
| The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters | 1-gen-2022 | Salvagno, Gl; Henry, Bm; Pighi, L; De Nitto, S; Gianfilippi, G; Lippi, G. | |
| Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster | 1-gen-2022 | Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe | |
| Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers | 1-gen-2021 | Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe |